Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Verma

Showing results (411-420 of 459) with videos related to

Pageof 46
Sort By:
Science Translational Medicine|May 7, 2025
Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemiasMeenakshi Venkatasubramanian, Leya Schwartz, Nandini Ramachandra, et al.
Nature Communications|February 23, 2016
MSI2 is required for maintaining activated myelodysplastic syndrome stem cellsJames Taggart, Tzu-Chieh Ho, Elianna Amin, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Ribosomal protein control of hematopoietic stem cell transformation through direct, non-canonical regulation of metabolismBryan Harris, Dinesh K Singh, Monika Verma, et al.
The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.
Blood|July 4, 2012
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsBritta Will, Li Zhou, Thomas O Vogler, et al.
Cancer Research|December 30, 2010
Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinaseLi Zhou, Christine McMahon, Tushar Bhagat, et al.
Cell Reports|December 31, 2013
Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesisJozef Madzo, Hui Liu, Alexis Rodriguez, et al.
Cancer Discovery|September 16, 2015
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 InhibitorsHaiying Cheng, Yiyu Zou, Jeffrey S Ross, et al.
Plos Genetics|April 13, 2011
Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesisHector Alvarez, Joanna Opalinska, Li Zhou, et al.
Cancer Cell|November 28, 2021
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancerLauren C Shapiro, Astha Thakkar, Sean T Campbell, et al.
Pageof 46

Showing results (411-420 of 459) with videos related to

Sort By:
Pageof 46
Science Translational Medicine|May 7, 2025
Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemiasMeenakshi Venkatasubramanian, Leya Schwartz, Nandini Ramachandra, et al.
Nature Communications|February 23, 2016
MSI2 is required for maintaining activated myelodysplastic syndrome stem cellsJames Taggart, Tzu-Chieh Ho, Elianna Amin, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Ribosomal protein control of hematopoietic stem cell transformation through direct, non-canonical regulation of metabolismBryan Harris, Dinesh K Singh, Monika Verma, et al.
The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.
Blood|July 4, 2012
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsBritta Will, Li Zhou, Thomas O Vogler, et al.
Cancer Research|December 30, 2010
Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinaseLi Zhou, Christine McMahon, Tushar Bhagat, et al.
Cell Reports|December 31, 2013
Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesisJozef Madzo, Hui Liu, Alexis Rodriguez, et al.
Cancer Discovery|September 16, 2015
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 InhibitorsHaiying Cheng, Yiyu Zou, Jeffrey S Ross, et al.
Plos Genetics|April 13, 2011
Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesisHector Alvarez, Joanna Opalinska, Li Zhou, et al.
Cancer Cell|November 28, 2021
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancerLauren C Shapiro, Astha Thakkar, Sean T Campbell, et al.
Pageof 46